뒤로
NervGen Pharma Corp(NGENF) 가격
NGENF 주가 차트
NGENF 배당금
NervGen Pharma Corp
$5.63
2.92%
$0.16
종가: Jan 16, 16:00:00 GMT-5
$5.63
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$5.47
시가
$5.3
일일 범위
$5.3 - $5.81
52주 범위
$1.5 - $6.3
거래량
27.4K
평균 거래량
143.6K
EPS(TTM)
-0.26
배당수익률
--
시가총액
$445.9M
NGENF란 무엇인가요?
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
